We are excited to pitch to potential investors at InvestMidwest on March 28-29 in St. Louis!

ProteoSense continues to look for fundraising opportunities as we develop our RapidScan™ pathogen detection platform. We are presently engaged in product testing and market research, with a slated RapidScan product launch of Q3/Q4 in 2018.

“We’re looking forward to the opportunity to present and meet with potential investors at InvestMidwest,” says ProteoSense President & CEO Mark Byrne. “We feel our product is perfect for this forum.”

InvestMidwest, now in its 19th year, is a venture capital conference that showcases life sciences, technology and food/ag/bioenergy companies from throughout the Midwest. The conference typically attracts over 300 attendees including investors from top venture capital firms, and has helped generate over $1 billion in investment in the past 17 years.

The conference will be held on March 28-29, 2018 at the Hilton St. Louis at the Ballpark.